Prostate News Archive
28-May-2011
Prostate Cancer Drug Zytiga May Extend Life
Title: prostate Cancer Drug Zytiga May Extend Life Category: Health News Created: 5/26/2011 11:01:00 AM Last Editorial Review: 5/26/2011 Prostate Cancer Studies Find Benefit in Daily Acetaminophen and Brisk Walks
Pop a Tylenol and take a brisk walk for protection against prostate cancer? That's what the findings of two new studies published this week suggest Zytiga Extends Lives of Prostate Cancer Patients, Study Says
Zytiga, made by Johnson & Johnson (JNJ) unit Centocor Ortho Biotech, gave men with advanced prostate cancer an average of four months of extra life, according to Phase III trial results published in the New England Journal of Medicine New Drug Extends Survival for Men With Advanced Prostate Cancer
THURSDAY, May 26 (HealthDay News) -- For men with advanced hormone-resistant prostate cancer who have also failed chemotherapy, the new drug Zytiga (abiraterone acetate) along with the steroid prednisone appears to boost survival, researchers report.
Back to Prostate News Archive